In the biopharmaceutical industry, the transport and storage of temperature-sensitive biosamples and pharmaceuticals—such as blood products, cells, biological tissues, and vaccines—require a consistently stable ultra-low temperature environment to maintain their viability and integrity. This demands exceptional insulation performance and reliability from transport equipment. Recently, Haier Biomedical's CryoBio Biobank Series Liquid Nitrogen Container and Low-Temperature Transport Trolley have gained significant recognition in the Japanese market, earning widespread praise and strong user preference.
Proven Excellence:
Trusted by Leading Pharmaceutical Companies
Designed specifically for hospitals, biobanks, and laboratories specializing in ultra-low temperature operations and sample transportation, Haier Biomedical's Low-Temperature Transport Trolley has earned the trust of multiple top pharmaceutical companies in Japan, fostering long-term partnerships. Notably, after an initial purchase, a leading pharmaceutical company was so impressed by the trolley's exceptional temperature stability and low liquid nitrogen consumption that they promptly placed a second order—further reaffirming Haier Biomedical's reputation for reliability and long-term trust, backed by superior product quality.
High Performance:
Engineered for Safe Transportation
Haier Biomedical's Low-Temperature Transport Trolley excels in both design and functionality. Constructed from high-quality stainless steel and advanced insulation materials, it delivers superior thermal performance and long-lasting durability. The trolley also features an intuitive LCD touchscreen interface, allowing users to easily operate various functions while monitoring temperature, liquid levels, and remaining service time in real-time—enhancing both convenience and efficiency.
Furthermore, with an impressive continuous operating capability of up to 24 hours, the trolley prodvides users with solid assurance, eliminating concerns about temperature fluctuations and product safety.
Looking ahead, Haier Biomedical remains committed to prioritizing user needs in its innovations, striving to deliver more reliable solutions for the life sciences sector. With a strong dedication to client satisfaction, the company will continue to drive progress and development within the industry.